MX2017016321A - Metodo para la deteccion y cuantificacion simultanea de virus de epstein-barr, citomegalovirus, herpesvirus humano 6, herpesvirus humano 7 y virus de sarcoma de kaposi mediante reaccion en cadena de la polimerasa en tiempo real, multiplex. - Google Patents

Metodo para la deteccion y cuantificacion simultanea de virus de epstein-barr, citomegalovirus, herpesvirus humano 6, herpesvirus humano 7 y virus de sarcoma de kaposi mediante reaccion en cadena de la polimerasa en tiempo real, multiplex.

Info

Publication number
MX2017016321A
MX2017016321A MX2017016321A MX2017016321A MX2017016321A MX 2017016321 A MX2017016321 A MX 2017016321A MX 2017016321 A MX2017016321 A MX 2017016321A MX 2017016321 A MX2017016321 A MX 2017016321A MX 2017016321 A MX2017016321 A MX 2017016321A
Authority
MX
Mexico
Prior art keywords
human herpesvirus
kaposi
epstein
cytomegalovirus
quantification
Prior art date
Application number
MX2017016321A
Other languages
English (en)
Inventor
M Fuentes Pananá Ezequiel
Morales Sánchez Abigail
SÁNCHEZ PONCE Yessica
Original Assignee
Hospital Infantil De Mexico Federico Gomez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital Infantil De Mexico Federico Gomez filed Critical Hospital Infantil De Mexico Federico Gomez
Priority to MX2017016321A priority Critical patent/MX2017016321A/es
Publication of MX2017016321A publication Critical patent/MX2017016321A/es
Priority to US16/772,714 priority patent/US20210032710A1/en
Priority to PCT/MX2019/000011 priority patent/WO2019117701A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se relaciona con un método para la detección y cuantificación múltiple y simultánea de cualquier combinación de los herpesvirus humanos de los géneros beta y gamma: Virus de Epstein-Barr (VEB), Citomegalovirus (CMV), Herpesvirus humano tipo 6 (HVH6), Herpesvirus humano tipo 7 (HVH7) y Virus de Sarcoma de Kaposi (VSK) y del gen endógeno humano beta-actina mediante reacción de amplificación de ADN usando la reacción en cadena de la polimerasa múltiplex en tiempo real.
MX2017016321A 2017-12-14 2017-12-14 Metodo para la deteccion y cuantificacion simultanea de virus de epstein-barr, citomegalovirus, herpesvirus humano 6, herpesvirus humano 7 y virus de sarcoma de kaposi mediante reaccion en cadena de la polimerasa en tiempo real, multiplex. MX2017016321A (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
MX2017016321A MX2017016321A (es) 2017-12-14 2017-12-14 Metodo para la deteccion y cuantificacion simultanea de virus de epstein-barr, citomegalovirus, herpesvirus humano 6, herpesvirus humano 7 y virus de sarcoma de kaposi mediante reaccion en cadena de la polimerasa en tiempo real, multiplex.
US16/772,714 US20210032710A1 (en) 2017-12-14 2019-02-14 Method For The Simultaneous Detection And Quantification Of Epstein-Barr Virus, Cytomegalovirus, Human Herpesvirus 6, Human Herpesvirus 7 and Kaposi's Sarcoma Virus Using A Multiplex, Real-Time Polymerase Chain Reaction
PCT/MX2019/000011 WO2019117701A2 (es) 2017-12-14 2019-02-14 Método para la detección y cuantificación simultánea de virus de epstein-barr, citomegalovirus, herpesvirus humano 6, herpesvirus humano 7 y virus de sarcoma de kaposi mediante reacción en cadena de la polimerasa en tiempo real, multiplex

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2017016321A MX2017016321A (es) 2017-12-14 2017-12-14 Metodo para la deteccion y cuantificacion simultanea de virus de epstein-barr, citomegalovirus, herpesvirus humano 6, herpesvirus humano 7 y virus de sarcoma de kaposi mediante reaccion en cadena de la polimerasa en tiempo real, multiplex.

Publications (1)

Publication Number Publication Date
MX2017016321A true MX2017016321A (es) 2019-01-14

Family

ID=65433924

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017016321A MX2017016321A (es) 2017-12-14 2017-12-14 Metodo para la deteccion y cuantificacion simultanea de virus de epstein-barr, citomegalovirus, herpesvirus humano 6, herpesvirus humano 7 y virus de sarcoma de kaposi mediante reaccion en cadena de la polimerasa en tiempo real, multiplex.

Country Status (3)

Country Link
US (1) US20210032710A1 (es)
MX (1) MX2017016321A (es)
WO (1) WO2019117701A2 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113930436A (zh) * 2021-10-28 2022-01-14 吉林正业生物制品股份有限公司 双标准曲线狂犬病毒阳性标准品质粒及其在定量检测狂犬病毒中的用途

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115029478B (zh) * 2021-11-16 2023-12-22 江汉大学 一种人巨细胞病毒的mnp标记位点、引物组合物、试剂盒及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040038282A1 (en) * 2000-10-27 2004-02-26 Applera Corporation Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
WO2004016219A2 (en) * 2002-08-14 2004-02-26 The Board Of Regents Of The University Of Texas System Clinical assays for the detection and typing of human herpesviruses
PT2007910T (pt) * 2006-03-31 2016-12-30 Mobidiag Oy Método e microchip para a detecção dos vírus do herpes
US9402895B2 (en) * 2007-08-15 2016-08-02 University of Pittsburg—Of the Commonwealth System of Higher Education Method of enhancing KSHV LANA1 immunogenicity
US8951723B2 (en) * 2009-02-12 2015-02-10 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Serological screening for HHV-8 infection using antigen mixtures
US20120122700A1 (en) * 2010-11-11 2012-05-17 University Of South Florida Materials and methods for determining subtelomere dna sequence

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113930436A (zh) * 2021-10-28 2022-01-14 吉林正业生物制品股份有限公司 双标准曲线狂犬病毒阳性标准品质粒及其在定量检测狂犬病毒中的用途

Also Published As

Publication number Publication date
WO2019117701A3 (es) 2019-08-29
WO2019117701A2 (es) 2019-06-20
US20210032710A1 (en) 2021-02-04

Similar Documents

Publication Publication Date Title
HRP20201406T1 (hr) Rekombinantni hcmv i rhcmv vektori koji kodiraju heterologni antigen izoliran iz virusa paramyxoviridae i njihove uporabe
CR20220190A (es) Compuestos de pirido [3,2-d] primidina como inmunomoduladores
Hook et al. Cytomegalovirus microRNAs
Fishman Overview: cytomegalovirus and the herpesviruses in transplantation
MX2017016321A (es) Metodo para la deteccion y cuantificacion simultanea de virus de epstein-barr, citomegalovirus, herpesvirus humano 6, herpesvirus humano 7 y virus de sarcoma de kaposi mediante reaccion en cadena de la polimerasa en tiempo real, multiplex.
EA201270632A1 (ru) 2'-фтор-6'-метилен карбоциклические нуклеозиды и способы лечения вирусных инфекций
Harkness et al. Transcription of the herpes simplex virus 1 genome during productive and quiescent infection of neuronal and nonneuronal cells
MX2016013341A (es) Agentes antiinflamatorios como compuestos virostaticos.
MX2022006322A (es) Moduladores de 5'-nucleotidasa, ecto y el uso de los mismos.
PH12018500855A1 (en) Herpes simplex virus vaccine
MX2015005500A (es) Nucleotidos de pirimidina y sus profarmacos de monofosfato para el tratamiento de infecciones virales y cancer.
GEP201706721B (en) Substituted nucleosides, nucleotides and analogs thereof
MX2017014550A (es) Inhibidores del antigeno nuclear epstein-barr 1 (ebna1) y metodos que los utilizan.
CA2807584C (en) 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
MX2013011915A (es) Analogos del n-nucleosido de pirimidina 1'-sustituida para tratamiento antiviral.
MX2015017556A (es) Nucleosidos sustituidos, nucleotidos y analogos de los mismos.
EA025278B9 (ru) Антивирусная композиция против заключенных или незаключенных в оболочку днк- или рнк-вирусов
MX2017001284A (es) Tieno [3,2-d] pirimidina, furo[3,2-d] pirimidina y pirrolo [3,2-d] pirimidinas utiles para el tratamiento de infecciones por virus sincitial respiratorio.
MX2021014525A (es) Adenovirus modificados.
NZ702146A (en) Peptides derived from viral proteins for use as immunogens and dosage reactants
Hicks et al. Current state of Marek's disease virus microRNA research
MX2020005680A (es) Tratamiento antisentido del sindrome de angelman.
Mahmoudian et al. Kinetics of transcription of infectious laryngotracheitis virus genes
Marin et al. Toll-like receptor activation and expression in bovine alpha-herpesvirus infections
Hu et al. Codon usage bias in human cytomegalovirus and its biological implication